nach oben

Erschienen in:

01.03.2024 | Clinical study

Risk of drug-induced liver injury differs between ARBs

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

The risk of suspected drug-induced liver injury (DILI) in patients receiving angiotensin receptor blocker (ARB) [angiotensin II receptor antagonist] treatment differs significantly between ARBs, according to findings of a study published in Drug Safety. …

Kim H, et al. Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea Drug Safety : 21 Mar 2024. Available from: URL: https://doi.org/10.1007/s40264-024-01418-4

Titel: Risk of drug-induced liver injury differs between ARBs
Publikationsdatum: 01.03.2024
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-55052-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Risk of drug-induced liver injury differs between ARBs

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Multiple drugs

Folinic acid

Anticoagulants/aspirin

BCG

Multiple drugs

Filgrastim